The SGLT2 inhibitor empagliflozin improves insulin sensitivity in db/db mice both as monotherapy and in combination with linagliptin. (Q50891421)
Jump to navigation
Jump to search
scientific article published on 13 November 2015
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | The SGLT2 inhibitor empagliflozin improves insulin sensitivity in db/db mice both as monotherapy and in combination with linagliptin. |
scientific article published on 13 November 2015 |
Statements
1 reference
The SGLT2 inhibitor empagliflozin improves insulin sensitivity in db/db mice both as monotherapy and in combination with linagliptin. (English)
1 reference
Matthias Blüher
1 reference
Nora Klöting
1 reference
Matthias Kern
1 reference
Michael Mark
1 reference
Eric Mayoux
1 reference
Thomas Klein
1 reference
13 November 2015
1 reference
1 reference
65
1 reference
114-123
1 reference
2
1 reference
Identifiers
1 reference